Stem Cell-Engineered Nanovesicles Exert Proangiogenic and Neuroprotective Effects

Area of Science:

• Biotechnology
• Regenerative Medicine
• Nanomedicine

Background:

• Mesenchymal stem cells (MSCs) show therapeutic potential but face challenges in survival, engraftment, and immunogenicity.
• MSC-derived exosomes offer promise but suffer from low yield and heterogeneity.
• A need exists for improved delivery systems for MSC-based regenerative therapies.

Purpose of the Study:

• To fabricate exosome-mimetic MSC-engineered nanovesicles (MSC-NVs) as a novel therapeutic agent.
• To characterize the size, markers, and contents of the fabricated MSC-NVs.
• To evaluate the therapeutic efficacy of MSC-NVs in tissue regeneration models.

Main Methods:

• Fabrication of MSC-NVs via serial extrusion of MSCs through filters.
• Characterization of MSC-NVs size (~120 nm) and surface markers (MSC and exosome markers).
• Assessment of MSC-NVs' therapeutic effects, including angiogenesis induction and neuroprotection.

Main Results:

• Successfully fabricated MSC-NVs with a significantly smaller size than parent MSCs.
• Confirmed presence of MSC and exosome markers, and encapsulation of therapeutic growth factors within MSC-NVs.
• Demonstrated comparable therapeutic effects to MSCs, including significant angiogenesis and neuroprotection.

Conclusions:

• MSC-NVs represent a viable nanosized therapeutic alternative for tissue regeneration.
• The engineered nanovesicles overcome limitations associated with MSCs and exosomes.
• MSC-NVs hold potential for advancing regenerative medicine strategies.